Sharp Drugs, Inc., West Hampton Beach, NY
Is Sharp Drugs, Inc. registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility, with FDA’s note “Ceased Compounding Operations”.
Does Sharp Drugs, Inc. hold a New York pharmacy license?
State pharmacy license records for New York are not checked: the Office of the Professions’ online verification search requires an access key and a check that the user is a person, and its bulk verification files are released only on request. This index reads only that state’s board actions.
Has Sharp Drugs, Inc. had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Aug 2, 2019), 1 state handoff letter (Oct 20, 2022) and 1 FMD-145 letter (Oct 20, 2022) for Sharp Drugs, Inc. State board actions: record found. The New York State Education Department’s list of Board of Regents disciplinary actions against pharmacy establishments lists “Application for consent order granted Penalty agreed upon 1 year probation, $5,000 fine” dated Dec 10, 2019, case Cal. No. 31244 on registration 016876. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Sharp Drugs, Inc.
- Location
- West Hampton Beach, NY
- Type as FDA labels it
- 503A
- FDA’s note
- Ceased Compounding Operations
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Oct 20, 2022
- FDA Data Dashboard inspections
- 2 inspections: 1 OAI, 1 NAI; 1 published Form 483
- State board records
- Not checked (license records); board actions matched: 1
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Sharp Drugs, Inc., a 503A facility, with 3 dated actions.
| Document | |||
|---|---|---|---|
| Oct 20, 2022 | State handoff letter | State Handoff Letter Issued 10/20/2022 | Not linked by FDA |
| Oct 20, 2022 | FMD-145 letter | FMD-145 Letter Issued 10/20/2022 | Not linked by FDA |
| Aug 2, 2019 | Warning letter | Warning Letter (08/02/2019) | FDA copy (archived) |
A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Sharp Drugs, Inc., Westhampton Beach, NY (FEI number 3014454961), matched to this page by exact name, city and state. It lists 2 inspections: 1 OAI, 1 NAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Apr 6, 2022 | No Action Indicated (NAI) | Drug Quality Assurance (Drugs) | 3014454961 | 1167411 |
| Jul 13, 2018 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3014454961 | 1060054 |
Form 483s FDA has published for this site
- Aug 1, 2018: Form 483 to Sharp Drugs, Inc., published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 1 Form 483 PDF for Sharp Drugs, Inc., but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Aug 1, 2018: FDA document 114951: the FEI number and firm name on its cover do not match this page by the rule.
State board of pharmacy records
State pharmacy license records for New York are not checked: the Office of the Professions’ online verification search requires an access key and a check that the user is a person, and its bulk verification files are released only on request. This index reads only that state’s board actions. Board actions source.
Board actions
As the board words them, newest first. An entry that is a complaint, charge or notice the board filed is a charge, not a final decision; only an order or final action records the outcome.
- Dec 10, 2019: “Application for consent order granted Penalty agreed upon 1 year probation, $5,000 fine.”, registration 016876, case Cal. No. 31244, SHARP DRUGS, INC., WESTHAMPTON BEACH, NY. Board list
What this covers: Board of Regents disciplinary actions against pharmacy establishments from the Office of the Professions’ summaries for the pharmacy profession, which start in 1994 (105 of 105 list pages read). These are final Regents actions, mostly consent orders; open complaints and charges not yet decided are not listed. Actions against individual pharmacists are not copied. New York pharmacy licenses and registrations are not checked. Actions in the data are dated Jan 14, 1994 to May 19, 2026.
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- New York State Education Department disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.